- METHOD OF CONTROLLING HARMFUL ARTHROPOD USING HETEROCYCLIC COMPOUND
-
PROBLEM TO BE SOLVED: To provide a method of controlling harmful arthropods. SOLUTION: An effective amount of a compound represented by formula (I) or an N oxide thereof is applied to harmful arthropods, a habitat of harmful arthropods, plants or the soil, [where Q is a group represented by Q1, or a group represented by Q2; Z is O or the like; A2 is CR4a or the like; A3 is N or CR4b or the like; B1 is CR1 or the like; B2 is N or CR6b or the like; B3 is N or CR6c or the like; G1 is N or CR3a; G2 is N or CR3b; G3 is N or CR3c; G4 is N or CR3d; R1 is a C1-C6 chain hydrocarbon group substituted with one or more substituents selected from the group consisting of a cyano group and a halogen atom, or the like; R2 is a C1-C6 alkyl group or the like; R3a, R3b, R3c and R3d are the same or different to represent a C1-C6 chain hydrocarbon group or the like; R4a, R4b, R6b and R6c are the same or different to represent H or the like; n is 0, 1 or 2.] SELECTED DRAWING: None COPYRIGHT: (C)2021,JPOandINPIT
- -
-
Paragraph 0313
(2020/11/28)
-
- HETEROCYCLIC COMPOUNDS AND NOXIOUS ARTHROPOD CONTROL AGENT CONTAINING SAME
-
The present invention provides a compound having an excellent control effect on a harmful arthropod. A compound represented by formula (I) [wherein Q represents a group represented by Q1 or a group represented b Q2; Z represents an oxygen atom or a sulfur
- -
-
Paragraph 1100-1101
(2021/01/21)
-
- HARMFUL ARTHROPOD CONTROLLING METHOD USING HETEROCYCLIC COMPOUND
-
PROBLEM TO BE SOLVED: To provide a harmful arthropod controlling method. SOLUTION: Harmful arthropods can be controlled by a compound represented by formula (I): Q-Pyridyl (RS(O) substituted) [where Q is a group represented by the formula Q1 or a group re
- -
-
Paragraph 0263
(2019/11/13)
-
- FUSED HETEROARYL DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS
-
Fused heteroaryl derivative compounds which are antagonists of orexin receptors are provided. The compounds can be used in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. Also provided is a composition which comprises the compound can be use to prevent or treat such diseases in which orexin receptors are involved.
- -
-
Page/Page column 57
(2016/07/27)
-
- Discovery of a potent, selective, and orally active phosphodiesterase 10A inhibitor for the potential treatment of schizophrenia
-
We report the discovery of a series of imidazo[1,2-a]pyrazine derivatives as novel inhibitors of phosphodiesterase 10A (PDE10A). In a high-throughput screening campaign we identified the imidazopyrazine derivative 1, a PDE10A inhibitor with limited select
- Bartolomé-Nebreda, José Manuel,Delgado, Francisca,Martín-Martín, María Luz,Martínez-Viturro, Carlos M.,Pastor, Joaquín,Tong, Han Min,Iturrino, Laura,Macdonald, Gregor J.,Sanderson, Wendy,Megens, Anton,Langlois, Xavier,Somers, Marijke,Vanhoof, Greet,Conde-Ceide, Susana
-
p. 4196 - 4212
(2014/06/09)
-
- IMIDAZO[1,2-a]PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
-
The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.
- -
-
Page/Page column 34
(2013/02/28)
-
- IMIDAZO [1, 2 -A] PYRAZINE DERIVATIVES AND THEIR USE FOR THE PREVENTION OR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC AND METABOLIC DISORDERS AND DISEASES
-
The present invention relates to novel imidazo[1,2-a]pyrazine derivatives which are inhibitors of the phosphodiesterase 10 enzyme (PDE10) and which are useful for the treatment or prevention of neurological, psychiatric and metabolic disorders in which the PDE10 enzyme is involved. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, to the use of such compounds or pharmaceutical compositions for the prevention or treatment of neurological, psychiatric and metabolic disorders and diseases.
- -
-
Page/Page column 75
(2011/10/05)
-
- IMIDAZO COMPOUNDS AND USES THEREOF
-
N-substituted imidazopyrazinone compounds such as N-alkylated/aralkylated 7H-imidazo[1,2-a]pyrazin-8-one compounds and related analogs are disclosed. Pharmaceutical compositions and kits containing the N-substituted imidazopyrazinone compounds, as well as therapeutic uses thereof, including treatment of arrhythmia, are also disclosed.
- -
-
Page/Page column 43
(2008/06/13)
-
- BETA-AMINO HETEROCYCLIC DIPEPTIDYL PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
The present invention is directed to compounds which are inhibitors of the dipeptidyl peptidase-IV enzyme ("DP-IV inhibitors") and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.
- -
-
Page/Page column 54
(2010/02/07)
-